Immunovant, Inc. (IMVT)
33.15
-0.02
(-0.06%)
USD |
NASDAQ |
Nov 19, 09:57
Immunovant Price to Book Value : 10.43 for Nov. 19, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 10.44 |
| November 17, 2026 | 10.45 |
| November 16, 2026 | 10.48 |
| November 13, 2026 | 10.76 |
| November 12, 2026 | 11.03 |
| November 11, 2026 | 11.66 |
| November 10, 2026 | 11.24 |
| November 09, 2026 | 11.06 |
| November 06, 2026 | 9.610 |
| November 05, 2026 | 8.936 |
| November 04, 2026 | 9.412 |
| November 03, 2026 | 9.141 |
| November 02, 2026 | 8.943 |
| October 30, 2026 | 9.182 |
| October 29, 2026 | 9.330 |
| October 28, 2026 | 9.260 |
| October 27, 2026 | 9.090 |
| October 26, 2026 | 8.867 |
| October 23, 2026 | 8.943 |
| October 22, 2026 | 9.160 |
| October 21, 2026 | 8.933 |
| October 20, 2026 | 8.999 |
| October 19, 2026 | 8.694 |
| October 16, 2026 | 8.414 |
| October 15, 2026 | 8.659 |
| Date | Value |
|---|---|
| October 14, 2026 | 8.782 |
| October 13, 2026 | 9.037 |
| October 12, 2026 | 9.279 |
| October 09, 2026 | 9.591 |
| October 08, 2026 | 9.525 |
| October 07, 2026 | 10.09 |
| October 06, 2026 | 10.11 |
| October 05, 2026 | 10.47 |
| October 02, 2026 | 10.58 |
| October 01, 2026 | 10.59 |
| September 30, 2026 | 10.63 |
| September 29, 2026 | 9.385 |
| September 28, 2026 | 9.393 |
| September 25, 2026 | 9.340 |
| September 24, 2026 | 9.536 |
| September 23, 2026 | 9.688 |
| September 22, 2026 | 10.46 |
| September 21, 2026 | 10.43 |
| September 18, 2026 | 10.36 |
| September 17, 2026 | 10.56 |
| September 16, 2026 | 10.20 |
| September 15, 2026 | 10.28 |
| September 14, 2026 | 10.56 |
| September 11, 2026 | 10.48 |
| September 10, 2026 | 10.69 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Roivant Sciences Ltd. | 7.026 |
| Ionis Pharmaceuticals, Inc. | 11.53 |
| Vertex Pharmaceuticals, Inc. | 6.428 |
| Heron Therapeutics, Inc. | 12.75 |
| TG Therapeutics, Inc. | 17.49 |
Price to Book Value Related Metrics
| Price | 33.15 |
| Earnings Yield | -7.70% |
| Market Cap | 6.855B |